Anal Squamous Cell Carcinoma in the HIV-Positive Patient

ABSTRACT

Epidermoid carcinoma of the anal canal is uncommon. The incidence of this disease has increased in HIV-positive men who have sex with men and the disease process is different from in HIV-negative patients. Modern therapy of HIV with highly active antiretroviral therapy (HAART) has improved the overall survival of HIV patients and allowed effective therapy for those who develop epidermoid carcinoma of the anal canal. This article describes the disease process and current treatment options.

KEYWORDS

Epidermoid carcinoma of the anus - HIV - anal cancer

REFERENCES

• 1 National Cancer Institute . Surveillance, Epidemiology, and End Results (SEER) Program.  Available at: http://seer.cancer.gov/csr/1975_2005/results_merged/sect_01_overview.pdf Accessed February 28, 2009; 
• 2 Diamond C, Taylor T H, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy.  Sex Transm Dis. 2005;  32(5) 314-320
• 3 Piketty C, Selinger-Leneman H, Grabar S FHDH-ANRS CO 4 et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.  AIDS. 2008;  22(10) 1203-1211
• 4 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342(11) 792-800
• 5 Palefsky J M. Human papillomavirus-related tumors.  AIDS. 2000;  14(Suppl 3) S189-S195
• 6 Cooper K, McGee J O. Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.  Mol Pathol. 1997;  50(1) 1-3
• 7 Gervaz P, Hahnloser D, Wolff B G et al.. Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients.  J Gastrointest Surg. 2004;  8(8) 1024-1030, discussion 1031
• 8 Kreuter A, Brockmeyer N H, Altmeyer P, Wieland U. German Competence Network HIV/AIDS . Anal intraepithelial neoplasia in HIV infection.  J Dtsch Dermatol Ges. 2008;  6(11) 925-934
• 9 Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus.  Br J Surg. 2006;  93(5) 531-538
• 10 Goldstone S. Anal dysplasia in men who have sex with men.  AIDS Read. 1999;  9(3) 204-208, 220
• 11 Patel H S, Silver A R, Northover J M. Anal cancer in renal transplant patients.  Int J Colorectal Dis. 2007;  22(1) 1-5
• 12 Mathews W C, Sitapati A, Caperna J C, Barber R E, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program.  J Acquir Immune Defic Syndr. 2004;  37(5) 1610-1615
• 13 Arain S, Walts A E, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions.  Cytojournal. 2005;  2(1) 4
• 14 Chiao E Y, Giordano T P, Palefsky J M, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.  Clin Infect Dis. 2006;  43(2) 223-233
• 15 Ferraris A, Narasimhan K, Rahman I, Jorge I. Anal Pap smear in high-risk patients: a poor screening tool.  South Med J. 2008;  101(11) 1185-1186
• 16 Cantor S B, Atkinson E N, Cardenas-Turanzas M, Benedet J L, Follen M, MacAulay C. Natural history of cervical intraepithelial neoplasia: a meta-analysis.  Acta Cytol. 2005;  49(4) 405-415
• 17 Ostör A G. Natural history of cervical intraepithelial neoplasia: a critical review.  Int J Gynecol Pathol. 1993;  12(2) 186-192
• 18 Mathews C, Caperna J, Cachay E R, Cosman B. Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations.  Open AIDS J. 2007;  1 11-20
• 19 Goldstone S E, Hundert J S, Huyett J W. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males.  Dis Colon Rectum. 2007;  50(5) 565-575
• 20 Nathan M, Hickey N, Mayuranathan L, Vowler S L, Singh N. Treatment of anal human papillomavirus-associated disease: a long term outcome study.  Int J STD AIDS. 2008;  19(7) 445-449
• 21 Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.  J Invest Dermatol. 2008;  128(8) 2078-2083
• 22 Chiao E Y, Krown S E, Stier E A, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.  J Acquir Immune Defic Syndr. 2005;  40(4) 451-455
• 23 Romassi M, Nagle D. Images in HIV/AIDS. The changing face of anal cancer.  AIDS Read. 2008;  18(4) 185-187
• 24 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report.  Dis Colon Rectum. 1974;  17(3) 354-356
• 25 Stadler R F, Gregorcyk S G, Euhus D M, Place R J, Huber P J, Simmang C L. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2004;  47(8) 1305-1309
• 26 Kim J H, Sarani B, Orkin B A et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44(10) 1496-1502
• 27 Edelman S, Johnstone P A. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.  Int J Radiat Oncol Biol Phys. 2006;  66(1) 206-211
• 28 Oehler-Jänne C, Huguet F, Provencher S et al.. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.  J Clin Oncol. 2008;  26(15) 2550-2557
• 29 Wexler A, Berson A M, Goldstone S E et al.. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2008;  51(1) 73-81
• 30 Seo Y, Kinsella M T, Reynolds H L, Chipman G, Remick S C, Kinsella T J. Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.  Int J Radiat Oncol Biol Phys. 2009;  , Epub ahead of print
• 31 Chiao E Y, Giordano T P, Richardson P, El-Serag H B. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.  J Clin Oncol. 2008;  26(3) 474-479
• 32 Schiller D E, Cummings B J, Rai S et al.. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.  Ann Surg Oncol. 2007;  14(10) 2780-2789